IP Library Granted Patent US 11,503,840
Granted Patent B2
US 11,503,840 · App. 17/103,351 · Granted Nov 22, 2022

Peptide and saccharide hydrolysate of cocoa beans, cosmetic compositions containing same, and cosmetic uses of same

Inventors: Corinne Coquet (Cipieres, FR); Catherine Gondran (Seillans, FR); Isabelle Imbert (Cannes, FR); Joel Mantelin (Cannes, FR); Nouha Domloge (Opio, FR); Sébastien Garnier (Le Rouret, FR); Jérémie Borsotto (Pegomas, FR); Esmeralda Cicchetti (Castets, FR); Florian Labarrade (Antibes, FR)
Assignees: ISP INVESTMENTS LLC.; JAFER ENTERPRISES R&D, S.L.
A23G1/30A23L33/105A23L33/18A61K8/60A61K8/645A61K8/97A61Q19/08C12N9/248C12N9/2437A23V2002/00A61K2800/522A61K2800/805C12Y302/01003C12Y302/01004C12Y302/01008C12Y302/01015
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,503,840
App. No.
17/103,351
Granted
Nov 22, 2022
Kind
B2
Abstract

Methods for decreasing harmful effects of blue light on skin are disclosed that include topically administering to a subject in need thereof a composition of an effective quantity of a purified, enzymatic hydrolysate of Theobroma cacao L. beans comprising peptides and saccharides having a molecular weight between 200 Da and 10 kDa in a physiologically acceptable medium. The hydrolysate of Theobroma cacao L. beans is present in the composition at a concentration from 0.001 to 20% with respect to the total weight of the composition. The composition can be a cosmetic composition.

Claims (22)

1. A method for decreasing harmful effects of blue light on skin, the method comprising:

topically administering to a subject in need thereof a composition comprising;

an effective quantity of a purified, enzymatic hydrolysate of Theobroma cacao L. beans comprising peptides and saccharides having a molecular weight between 200 Da and 10 kDa, and

a physiologically acceptable medium.

2. The method according to claim 1 , wherein the hydrolysate of Theobroma cacao L. beans is present in the composition at a concentration from 0.001 to 20% with respect to the total weight of the composition.

3. The method according to claim 1 , wherein the composition is a cosmetic composition.

4. The method according to claim 1 , wherein topically administering comprises application two times per day.

5. The method according to claim 1 , wherein the composition reduces cellular reactive oxygenated species generated by exposure of skin to blue light.

6. The method according to claim 1 , wherein the concentration of the hydrolysate of Theobroma cacao L. beans is from 0.1 to 10% with respect to the total weight of the composition.

7. The method according to claim 1 , wherein the concentration of the hydrolysate of Theobroma cacao L. beans is from 0.2 to 5% with respect to the total weight of the composition.

8. The method according to claim 1 , wherein the concentration of the hydrolysate of Theobroma cacao L. beans is from 0.5 to 1.5% with respect to the total weight of the composition.

9. A method for decreasing harmful effects of blue light, improving the barrier function, and decreasing the appearance of the signs of aging and photoaging of the skin, the method comprising:

topically administering to a subject in need thereof a composition comprising;

an effective quantity of a purified, enzymatic hydrolysate of Theobroma cacao L. beans comprising peptides and saccharides having a molecular weight between 200 Da and 10 kDa, and

a physiologically acceptable medium.

10. The method according to claim 9 , wherein the hydrolysate of Theobroma cacao L. beans is present in the composition at a concentration from 0.001 to 20% with respect to the total weight of the composition.

11. The method according to claim 9 , wherein the composition is a cosmetic composition.

12. The method according to claim 9 , wherein topically administering comprises application two times per day.

13. The method according to claim 9 , wherein the composition reduces cellular reactive oxygenated species generated by exposure of skin to blue light.

14. The method according to claim 9 , wherein the concentration of the hydrolysate of Theobroma cacao L. beans is from 0.1 to 10% with respect to the total weight of the composition.

15. The method according to claim 9 , wherein the concentration of the hydrolysate of Theobroma cacao L. beans is from 0.2 to 5% with respect to the total weight of the composition.

16. The method according to claim 9 , wherein the concentration of the hydrolysate of Theobroma cacao L. beans is from 0.5 to 1.5% with respect to the total weight of the composition.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2020
From: COQUET, CORINNE; GONDRAN, CATHERINE; IMBERT, ISABELLE; MANTELIN, JOEL; LABARRADE, FLORIAN; DOMLOGE, NOUHA
To: ISP INVESTMENTS LLC
Reel/Frame 054513/0456 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 2, 2020
From: GARNIER, SÈBASTIEN; BORSOTTO, JÉRÉMIE; CICCHETTI, ESMERALDA
To: JAFER
Reel/Frame 054513/0642 →
CHANGE OF NAME Recorded Dec 2, 2020
From: JAFER
To: JAFER ENTERPRISES R&D, S.L
Reel/Frame 054513/0712 →
Priority Claims (1)
FR 1600441 · Mar 16, 2016 · national
Continuity (2)
Continuation 16084783
Related Publication 20210106022A1 · Apr 15, 2021